Skip to main content
. Author manuscript; available in PMC: 2013 Sep 16.
Published in final edited form as: Crit Care Clin. 2009 Apr;25(2):325–Contents. doi: 10.1016/j.ccc.2009.01.002

Table 7.

Independent Data Safety Monitoring Cardiac Sub committee Assignation of Myocardial infarction

Cardiac Committee Determination As Treated (n = 714)
PolyHeme (n = 349)
Control (n = 365)
n % n %
Chest AIS ≤ 2

 Probable infarction 19 5.4 11 3.0

 Physiologic stress or possible infarction 58 16.6 67 18.4

 Possible infarction 5 1.4 6 1.6

 Total possible or probable infarction 82 23.4 84 23.0

 Absent infarction 61 17.5 52 14.2

 Indetermine infarction 49 14.0 79 21.6

Chest AIS > 2

 Probable infarction or injury 23 6.6 19 5.2

 Physiologic stress or possible infarction or injury 81 23.2 80 21.9

 Possible infarction or injury 1 0.3 6 1.6

 Total possible or probable infarction or injury 105 30.1 105 28.8

 Absent infarction or injury 22 6.3 12 3.3

 Indetermine infarction or injury 30 8.6 33 9.0

Values expressed as n (%); percentages are based on the number of patients in each treatment group divided by number of patients who had nonmissing values.

Data from Moore EE, Moore FA, Fabian TC, et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA Multicenter Trial. J Am Coll Surg 2009;208:1–13.